Literature DB >> 33615349

Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study.

Til Stürmer, Michael Webster-Clark, Jennifer L Lund, Richard Wyss, Alan R Ellis, Mark Lunt, Kenneth J Rothman, Robert J Glynn.   

Abstract

To extend previous simulations on the performance of propensity score (PS) weighting and trimming methods to settings without and with unmeasured confounding, Poisson outcomes, and various strengths of treatment prediction (PS c statistic), we simulated studies with a binary intended treatment T as a function of 4 measured covariates. We mimicked treatment withheld and last-resort treatment by adding 2 "unmeasured" dichotomous factors that directed treatment to change for some patients in both tails of the PS distribution. The number of outcomes Y was simulated as a Poisson function of T and confounders. We estimated the PS as a function of measured covariates and trimmed the tails of the PS distribution using 3 strategies ("Crump," "Stürmer," and "Walker"). After trimming and reestimation, we used alternative PS weights to estimate the treatment effect (rate ratio): inverse probability of treatment weighting, standardized mortality ratio (SMR)-treated, SMR-untreated, the average treatment effect in the overlap population (ATO), matching, and entropy. With no unmeasured confounding, the ATO (123%) and "Crump" trimming (112%) improved relative efficiency compared with untrimmed inverse probability of treatment weighting. With unmeasured confounding, untrimmed estimates were biased irrespective of weighting method, and only Stürmer and Walker trimming consistently reduced bias. In settings where unmeasured confounding (e.g., frailty) may lead physicians to withhold treatment, Stürmer and Walker trimming should be considered before primary analysis.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bias (epidemiology); epidemiologic methods; propensity score; simulation study; trimming; unmeasured confounding; variance; weighting

Mesh:

Year:  2021        PMID: 33615349      PMCID: PMC8327194          DOI: 10.1093/aje/kwab041

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

2.  Insights into different results from different causal contrasts in the presence of effect-measure modification.

Authors:  Til Stürmer; Kenneth J Rothman; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-10       Impact factor: 2.890

3.  Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm.

Authors:  Carmen C Cuthbertson; Anna Kucharska-Newton; Keturah R Faurot; Til Stürmer; Michele Jonsson Funk; Priya Palta; B Gwen Windham; Sydney Thai; Jennifer L Lund
Journal:  Epidemiology       Date:  2018-07       Impact factor: 4.822

4.  Restriction of Pharmacoepidemiologic Cohorts to Initiators of Medications in Unrelated Preventive Drug Classes to Reduce Confounding by Frailty in Older Adults.

Authors:  Henry T Zhang; Leah J McGrath; Alan R Ellis; Richard Wyss; Jennifer L Lund; Til Stürmer
Journal:  Am J Epidemiol       Date:  2019-07-01       Impact factor: 4.897

5.  Target Validity and the Hierarchy of Study Designs.

Authors:  Daniel Westreich; Jessie K Edwards; Catherine R Lesko; Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

6.  Addressing Extreme Propensity Scores via the Overlap Weights.

Authors:  Fan Li; Laine E Thomas; Fan Li
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

7.  RE:"ADDRESSING EXTREME PROPENSITY SCORES VIA THE OVERLAP WEIGHTS".

Authors:  Fan Li; Laine E Thomas; Fan Li
Journal:  Am J Epidemiol       Date:  2021-01-04       Impact factor: 4.897

8.  Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution.

Authors:  Robert J Glynn; Mark Lunt; Kenneth J Rothman; Charles Poole; Sebastian Schneeweiss; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-05       Impact factor: 2.890

9.  Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

Authors:  Til Stürmer; Kenneth J Rothman; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2010-08-17       Impact factor: 4.897

10.  Different methods of balancing covariates leading to different effect estimates in the presence of effect modification.

Authors:  Mark Lunt; Daniel Solomon; Kenneth Rothman; Robert Glynn; Kimme Hyrich; Deborah P M Symmons; Til Stürmer
Journal:  Am J Epidemiol       Date:  2009-01-19       Impact factor: 4.897

View more
  6 in total

1.  Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures.

Authors:  Anne M Butler; Derek S Brown; Michael J Durkin; John M Sahrmann; Katelin B Nickel; Caroline A O'Neil; Margaret A Olsen; David Y Hyun; Rachel M Zetts; Jason G Newland
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.

Authors:  Nuala J Meyer; Michael G S Shashaty; Todd A Miano; Sean Hennessy; Wei Yang; Thomas G Dunn; Ariel R Weisman; Oluwatosin Oniyide; Roseline S Agyekum; Alexandra P Turner; Caroline A G Ittner; Brian J Anderson; F Perry Wilson; Raymond Townsend; John P Reilly; Heather M Giannini; Christopher V Cosgriff; Tiffanie K Jones
Journal:  Intensive Care Med       Date:  2022-07-14       Impact factor: 41.787

3.  Evaluating sensitivity to classification uncertainty in latent subgroup effect analyses.

Authors:  Wen Wei Loh; Jee-Seon Kim
Journal:  BMC Med Res Methodol       Date:  2022-09-24       Impact factor: 4.612

4.  Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data.

Authors:  Andrei Barbulescu; Johan Askling; Saedis Saevarsdottir; Seoyoung C Kim; Thomas Frisell
Journal:  Clin Pharmacol Ther       Date:  2022-06-23       Impact factor: 6.903

Review 5.  Matching Methods for Confounder Adjustment: An Addition to the Epidemiologist's Toolbox.

Authors:  Noah Greifer; Elizabeth A Stuart
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 4.280

6.  Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS).

Authors:  Ivan Lerner; Arnaud Serret-Larmande; Bastien Rance; Nicolas Garcelon; Anita Burgun; Laurent Chouchana; Antoine Neuraz
Journal:  JMIR Med Inform       Date:  2022-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.